PTC Therapeutics
A biopharmaceutical company focused on discovery and development of small-molecule drugs to treat genetic and rare diseases.
All edits by Cameron Porter
Edits on 30 Apr, 2019
Cameron Porter
Edits made to:
Article (+22/-22 characters)
Article
In August 2018, PTC announced its acquisition of Agilis BiotherapeuticsAgilis Biotherapeutics, a private biotechnology company focused on the development of gene therapy programs for rare genetic disorders that affect the central nervous system. Through this acquisition, PTC added GT-AADC, an adeno-associated virus (AAV) gene therapy that treats Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency.
Find more companies like PTC Therapeutics
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
By using this site, you agree to our Terms of Service.